Literature DB >> 20360314

Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder.

Roy H Perlis1, Jordan W Smoller, Jayalakshmi Mysore, Mei Sun, Tammy Gillis, Shaun Purcell, Marcella Rietschel, Markus M Nöthen, Stephanie Witt, Wolfgang Maier, Dan V Iosifescu, Patrick Sullivan, A John Rush, Maurizio Fava, Hans Breiter, Marcy Macdonald, James Gusella.   

Abstract

OBJECTIVE: Presymptomatic individuals with the Huntingtin (HTT) CAG expansion mutation that causes Huntington's disease may have higher levels of depressive symptoms than healthy comparison populations. However, the prevalence of HTT CAG repeat expansions among individuals diagnosed with major depressive disorder has not been established.
METHOD: This was a case-control genetic association study of HTT CAG allele size in two discovery cohorts of individuals with major depressive disorder and comparison subjects without major depression as well as a replication cohort of individuals with major depression and comparison subjects without major depression.
RESULTS: CAG repeat lengths of 36 or greater were observed in six of 3,054 chromosomes from individuals with major depression, compared with none of 4,155 chromosomes from comparison subjects. In a third cohort, one expanded allele was observed among 1,202 chromosomes in the major depression group, compared with none of 2,678 chromosomes in comparison subjects. No clear pattern of clinical features was shared among individuals with the expanded repeats.
CONCLUSIONS: In clinical populations of individuals diagnosed with major depression, approximately 3 in 1,000 carried expanded HTT CAG alleles.

Entities:  

Mesh:

Year:  2010        PMID: 20360314      PMCID: PMC3114558          DOI: 10.1176/appi.ajp.2009.09070973

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  37 in total

1.  Depression as a risk factor for Alzheimer disease: the MIRAGE Study.

Authors:  Robert C Green; L Adrienne Cupples; Alex Kurz; Sanford Auerbach; Rodney Go; Dessa Sadovnick; Ranjan Duara; Walter A Kukull; Helena Chui; Timi Edeki; Patrick A Griffith; Robert P Friedland; David Bachman; Lindsay Farrer
Journal:  Arch Neurol       Date:  2003-05

2.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

3.  The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset.

Authors:  J Michael Andresen; Javier Gayán; Luc Djoussé; Simone Roberts; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; James F Gusella; Marcy E MacDonald; Richard H Myers; David E Housman; Nancy S Wexler
Journal:  Ann Hum Genet       Date:  2006-12-19       Impact factor: 1.670

4.  Prefrontal and striatal activation during sequence learning in geriatric depression.

Authors:  Howard J Aizenstein; Meryl A Butters; Jennifer L Figurski; V Andrew Stenger; Charles F Reynolds; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2005-08-15       Impact factor: 13.382

5.  Increased risk for recurrent major depression in DYT1 dystonia mutation carriers.

Authors:  G A Heiman; R Ottman; R J Saunders-Pullman; L J Ozelius; N J Risch; S B Bressman
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

6.  Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression.

Authors:  Donald A Malone; Darin D Dougherty; Ali R Rezai; Linda L Carpenter; Gerhard M Friehs; Emad N Eskandar; Scott L Rauch; Steven A Rasmussen; Andre G Machado; Cynthia S Kubu; Audrey R Tyrka; Lawrence H Price; Paul H Stypulkowski; Jonathon E Giftakis; Mark T Rise; Paul F Malloy; Stephen P Salloway; Benjamin D Greenberg
Journal:  Biol Psychiatry       Date:  2008-10-08       Impact factor: 13.382

7.  Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

Authors:  A John Rush; Maurizio Fava; Stephen R Wisniewski; Philip W Lavori; Madhukar H Trivedi; Harold A Sackeim; Michael E Thase; Andrew A Nierenberg; Frederic M Quitkin; T Michael Kashner; David J Kupfer; Jerrold F Rosenbaum; Jonathan Alpert; Jonathan W Stewart; Patrick J McGrath; Melanie M Biggs; Kathy Shores-Wilson; Barry D Lebowitz; Louise Ritz; George Niederehe
Journal:  Control Clin Trials       Date:  2004-02

8.  Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder.

Authors:  Diego A Pizzagalli; Avram J Holmes; Daniel G Dillon; Elena L Goetz; Jeffrey L Birk; Ryan Bogdan; Darin D Dougherty; Dan V Iosifescu; Scott L Rauch; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2009-05-01       Impact factor: 18.112

9.  Limbic and frontal cortical degeneration is associated with psychiatric symptoms in PINK1 mutation carriers.

Authors:  Kathrin Reetz; Rebekka Lencer; Susanne Steinlechner; Christian Gaser; Johann Hagenah; Christian Büchel; Dirk Petersen; Norman Kock; Ana Djarmati; Hartwig R Siebner; Christine Klein; Ferdinand Binkofski
Journal:  Biol Psychiatry       Date:  2008-02-07       Impact factor: 13.382

10.  Current estimates from the National Health Interview Survey, 1995.

Authors:  V Benson; M A Marano
Journal:  Vital Health Stat 10       Date:  1998-10
View more
  23 in total

1.  [Huntington's chorea mimicking adult attention deficit hyperactivity disorder].

Authors:  M Kraemer; S Haertig; A Hill; J Uekermann; J Wiltfang; B Kis
Journal:  Nervenarzt       Date:  2011-03       Impact factor: 1.214

Review 2.  Interactome networks and human disease.

Authors:  Marc Vidal; Michael E Cusick; Albert-László Barabási
Journal:  Cell       Date:  2011-03-18       Impact factor: 41.582

3.  Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.

Authors:  Paul G Unschuld; Suresh E Joel; James J Pekar; Sarah A Reading; Kenichi Oishi; Julie McEntee; Megan Shanahan; Arnold Bakker; Russell L Margolis; Susan S Bassett; Adam Rosenblatt; Susumu Mori; Peter C van Zijl; Christopher A Ross; Graham W Redgrave
Journal:  Psychiatry Res       Date:  2012-09-11       Impact factor: 3.222

4.  Haplotype-based stratification of Huntington's disease.

Authors:  Michael J Chao; Tammy Gillis; Ranjit S Atwal; Jayalakshmi Srinidhi Mysore; Jamshid Arjomand; Denise Harold; Peter Holmans; Lesley Jones; Michael Orth; Richard H Myers; Seung Kwak; Vanessa C Wheeler; Marcy E MacDonald; James F Gusella; Jong-Min Lee
Journal:  Eur J Hum Genet       Date:  2017-08-23       Impact factor: 4.246

Review 5.  Tandem repeats mediating genetic plasticity in health and disease.

Authors:  Anthony J Hannan
Journal:  Nat Rev Genet       Date:  2018-02-05       Impact factor: 53.242

Review 6.  Edgotype: a fundamental link between genotype and phenotype.

Authors:  Nidhi Sahni; Song Yi; Quan Zhong; Noor Jailkhani; Benoit Charloteaux; Michael E Cusick; Marc Vidal
Journal:  Curr Opin Genet Dev       Date:  2013-11-26       Impact factor: 5.578

7.  Retinal Nerve Fiber Layer Thickness Measurement by Spectral-Domain Optical Coherence Tomography in Patients with Major Depressive Disorder.

Authors:  İpek Sönmez; Ferdi Köşger; Ümit Aykan
Journal:  Noro Psikiyatr Ars       Date:  2017-03       Impact factor: 1.339

Review 8.  The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders.

Authors:  Jordan W Smoller
Journal:  Neuropsychopharmacology       Date:  2015-08-31       Impact factor: 7.853

9.  Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy.

Authors:  Jong-Min Lee; Ekaterina I Galkina; Rachel M Levantovsky; Elisa Fossale; Mary Anne Anderson; Tammy Gillis; Jayalakshmi Srinidhi Mysore; Kathryn R Coser; Toshi Shioda; Bin Zhang; Matthew D Furia; Jonathan Derry; Isaac S Kohane; Ihn Sik Seong; Vanessa C Wheeler; James F Gusella; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2013-04-16       Impact factor: 6.150

10.  Differential hippocampal gene expression and pathway analysis in an etiology-based mouse model of major depressive disorder.

Authors:  George S Zubenko; Hugh B Hughes; Rick M Jordan; James Lyons-Weiler; Bruce M Cohen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-07-25       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.